CEP of Fosfomycin Trometamol Newly Authorized!

We are proud to announce that our Fosfomycin Trometamol API has officially received EU CEP certification (Certificate No. 2024-168-Rev00) from the EDQM.We warmly invite global partners to connect with us and explore new avenues for collaboration.

This milestone underscores that our quality system, manufacturing processes, and product fully comply with European Pharmacopoeia standards, paving the way for broader access to the EU and other highly regulated global markets.Looking ahead, we remain dedicated to our value of “Benchmarking Global Quality, Driving the Future with Innovation.” We will continue to expand our portfolio in the field of cardiovascular, anti-infective, CNS, and antidepressant of APIs and advanced intermediates.